Answer
Grazax is a disease-modifying treatment for grass pollen-induced rhinitis and conjunctivitis in adults and children aged 5 years or older with clinically relevant symptoms and a positive skin prick test and/or specific IgE test to grass pollen.
Sources for this answer
- GRAZAX 75,000 SQ-T sublingual lyophilisateALK-Abello Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 17Document updated
Sources checked